Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Arbutus Biopharma Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 131 | +13 |
| Shares | 83.4M | 5.00K | 96.7M | +13.3M (+16.0%) |
| Value | $215.2M | $12.9K | $298.4M | +$83.2M (+38.7%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (10)
Institutions that held Arbutus Biopharma Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Lighthouse Investment Partners, LLC | 99,055 | $255.6K |
| American International Group, Inc. | 62,439 | $161.1K |
| GTS Securities LLC | 50,110 | $129.3K |
| SG Americas Securities, LLC | 19,644 | $51.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 13,268 | $34.2K |
| Federated Hermes, Inc. | 11,033 | $28.5K |
| Brevan Howard Capital Management LP | 10,482 | $27.0K |
| Metropolitan Life Insurance Co | 4,340 | $11.2K |
| Financial Synergies Wealth Advisors, Inc. | 3,600 | $9.29K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 24 | $61 |
Not filed for Q2 2024 yet (1)
Institutions that held Arbutus Biopharma Corp at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cambridge Trust Co | 5,000 | $12.9K |